List of publication 2019

  1. Albrecht J*, Zielińska M: Exchange-mode glutamine transport across CNS cell membranes. Neuropharmacology 2019 Dec 15;161:107560. doi: 10.1016/j.neuropharm.2019.03.003. (invited review) IF2018=4.367; IF5Y=4.494; Q1; 140 pkt;
  2. Ambroziak M*, Kuryłowicz A, Budaj A: Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients. Journal of Thrombosis and Thrombolysis 2019 Oct;48(3):519-527. doi: 10.1007/s1123. (original) IF2018=2.789; IF5Y=2.213; Q2; 70 pkt;
  3. Andrzejewska A, Jabłonska A, Seta (Podobińska) M, Dąbrowska S, Walczak P, Janowski M, Łukomska B*: Labeling of human mesenchymal stem cells with different classes of vital stains: robustness and toxicity. Stem Cell Research and Therapy 2019 Jun 25;10(1):187. doi: 10.1186/s13287-019-1296-8. (original) IF2018=4.627; IF5Y=5.363; Q1; 100 pkt;
  4. Andrzejewska A, Lukomska B, Janowski M*: Concise review: mesenchymal stem cells: from roots to boost. Stem Cells 2019 Jul;37(7):855-864. doi: 10.1002/stem.3016. (review) IF2018=5.614; IF5Y=5.981; Q1; 140 pkt;
  5. Andrzejewska A, Nowakowski A, Grygorowicz T, Dąbrowska S, Orzel J, Walczak P, Lukomska B, Janowski M*: Single-cell, high-throughput analysis of cell docking to vessel wall. Journal of Cerebral Blood Flow & Metabolism 2019 Nov;39(11):2308-2320. doi: 10.1177/0271678X18805238. (original) IF2018=6.040;IF5Y=5.770; Q1; 140 pkt;  
  6. Andrzejewski K, Budzińska K, Kaczyńska K*: Effect of 6-OHDA on hypercapnic ventilatory response in the rat model of Parkinson’s disease. Physiological Research 2019;68:285-293. (original) IF2018=1.701;IF5Y=1.669; Q4; 40 pkt;
  7. Augustyniak J, Bertero A, Coccini T, Baderna D, Buzanska L, Caloni F*: Organoids are promising tools for species-specific in vitro toxicological studies. Journal of Applied Toxicology 2019 Dec;39(12):1610-1622. doi: 10.1002/jat.3815. (review) IF2018=3.065; IF5Y=2.975; Q2; 100 pkt;  
  8. Augustyniak J, Lenart J, Gaj P, Kolanowska M, Jazdzewski K, Stepien PP, Buzanska L*: Bezafibrate upregulates mitochondrial biogenesis and influence neural differentiation of human-induced pluripotent stem cells. Molecular Neurobiology 2019 Jun;56(6):4346-4363. doi: 10.1007/s12035-018-1368-2. (original) IF2018=4.586; IF5Y=4.643; Q1; 100 pkt;
  9. Augustyniak J, Lenart J*, Lipka G, Stepien PP, Buzanska L*: Reference gene validation via RT-qPCR for human iPSC-derived neural stem cells and neural progenitors. Molecular Neurobiology 2019;56(10):6820-6832. doi: 10.1007/s12035-019-1538-x. (original) IF2018=4.586; IF5Y=4.643; Q1;100 pkt;
  10. Bądzyńska B*, Baranowska I, Gawryś O, Sadowski J: Evidence against a crucial role of renal medullary perfusion in blood pressure control of hypertensive rats. Journal of Physiology - London  2019 Jan;597(1):211-223. doi: 10.1113/JP276342. (original) IF2018=4.950; IF5Y=4.925; Q1; 100 pkt;
  11. Bejm K*, Wojtkiewicz S, Sawosz P, Perdziak M, Pastuszak Ż, Sudakou A, Guchek P, Liebert A: Influence of contrast-reversing frequency on amplitude and spatial distribution of visual cortex hemodynamic responses. Biomedical Optics Express 2019:10(12):6296-6312. (original) IF2018=3.910; IF5Y=3.757; Q1; 140 pkt;
  12. Bertero A, Augustyniak J, Buzanska L, Caloni F*: Species-specific models in toxicology: in vitro epithelial barriers. Environmental Toxicology and Pharmacology 2019 Aug;70:103203. doi: 10.1016/j.etap.2019.103203. (review) IF2018=3.061; IF5Y=3.029; Q2; 70 pkt;
  13. Bilezikian JP*, Lin CJF, Brown JP, Wang AT, Yin X, Ebeling PR, Fahrleitner-Pammer A, Franek E, Gilchrist N, Miller PD, Simon JA, Valter I,Zerbini CAF, Libanati C, Chines A: Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group. Osteoporosis International 2019 Sep;30(9):1855-1864. doi: 10.1007/s00198-019-05020-8. (original) IF2018=3.830; IF5Y=3.899; Q2; 140 pkt;
  14. Bilmin K, Kujawska T, Grieb P: Sonodynamic therapy for gliomas. Perspectives and prospects of selective sonosensitization of glioma cells. Cells 2019 Nov 13;8(11):E1428. doi: 10.3390/cells8111428. (review) IF2018=5.656; IF5Y=NA; Q1; 140 pkt;
  15. Bohush A, Bieganowski P,  Filipek A*: Hsp90 and its co-chaperones in neurodegenerative diseases.  International Journal of Molecular Sciences 2019;20:4976. doi:10.3390/ijms20204976. IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  16. Bosiacki M, Gąssowska-Dobrowolska M, Kojder K, Fabiańska M, Jeżewski D, Gutowska I, Lubkowska A*: Perineuronal nets and their role in synaptic homeostasis. International Journal of Molecular Sciences 2019 Aug 22;20(17):4108. doi: 10.3390/ijms20174108. (review) IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  17. Brodziak A, Sobczuk P, Bartnik E, Fiedorowicz M, Porta C, Szczylik C, Czarnecka AM*: Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities. Nature Reviews Urology 2019 Nov;16:655-673. doi: 10.1038/s41585-019-0233-z. (review) IF2018=9.333; IF5Y=8.079; Q1; 140 pkt;
  18. Brzoska E, Kalkowski L, Kowalski K, Michalski P, Kowalczyk P, Mierzejewski B, Walczak P, Ciemerych MA, Janowski M*: Muscular contribution to adolescent idiopathic scoliosis from the perspective of stem cell-based regenerative medicine. Stem Cells and Development 2019 Aug 15;28(16):1059-1077. doi: 10.1089/scd.2019.0073. IF2018=3.147; IF5Y=3.590; Q2; 100 pkt;
  19. Čertíková Chábová V, Kujal P, Vaňourková Z, Škaroupková P, Sadowski J, Kompanowska-Jezierska E, Tesař V, Hammock B, Imig J, Maxová H, Červenka L, Vaněčková I*: Addition of endothelin A-receptor blockade spoils the beneficial effect of combined renin-angiotensin and soluble epoxide hydrolase inhibition: studies on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Kidney & Blood Pressure Research  2019;44(6):1493-1505. doi: 10.1159/000504137. (original) IF2018=2.123; IF5Y=1.996; Q2; 70 pkt;
  20. Chioncel O, Mebazaa A, Maggioni AP, Harjola VP, Rosano G, Laroche C, Piepoli MF, Crespo-Leiro MG, Lainscak M, Ponikowski P, Filippatos G, Ruschitzka F, Seferovic P, Coats AJS, Lund LH; ESC-EORP HFA Heart Failure Long-Term Registry Investigators. Collaborators (599, Pawlak A): Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. European Journal of Heart Failure 2019;21(11):1338-1352. doi: 10.1002/ejhf.1492. (original) IF2018=12.129; IF5Y=9.014; Q1; 200 pkt;
  21. Ciechanowicz P, Rakowska A*, Sikora M, Rudnicka L: JAK-inhibitors in dermatology: current evidence and future applications. Journal of Dermatological Treatment 2019 Nov;30(7):648-658. doi: 10.1080/09546634.2018.1546043. (review) IF2018=2.112; IF5Y=1.891; Q2; 70 pkt;
  22. Czarnecka AM*, Teterycz P, Mariuk-Jarema A, Lugowska I, Rogala P, Dudzisz-Sledz M, Switaj T, Rutkowski P: Treatment sequencing and clinical outcomes in BRAF-positive and BRAF-negative unresectable and metastatic melanoma patients treated with new systemic therapies in routine practice. Targeted Oncology 2019;14(6):729-742. doi: 10.1007/s11523-019-00688-8. (original) IF2018=3.683; IF5Y=3.118; Q2; 100 pkt;
  23. Czubowicz K, Jęśko H, Wencel P, Lukiw WJ, Strosznajder RP*: The role of ceramide and sphingosine-1-phosphate in Alzheimer's disease and other neurodegenerative disorders. Molecular Neurobiology 2019 Aug;56(8):5436-5455. doi: 10.1007/s12035-018-1448-3. (review) IF2018=4.586; IF5Y=4.643; Q1; 100 pkt; 
  24. Daniluk P*, Firlik G, Lesyng B: Implementation of a maximum clique search procedure on CUDA. Journal of Heuristics 2019 April;25(2):247-271. (original) IF2018=1.392; IF5Y=1.788; Q2; 70 pkt;
  25. Dąbrowska K, Zielińska M*: Silencing of transcription factor Sp1 promotes SN1 transporter regulation by ammonia in mouse cortical astrocytes. International Journal of Molecular Sciences 2019 Jan 9;20(2):234. doi: 10.3390/ijms20020234. (original) IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  26. Dąbrowska S, Andrzejewska A, Łukomska B, Janowski M*: Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles. Journal of Neuroinflammation 2019 Sep 12;16(1):178. doi: 10.1186/s12974-019-1571-8. (review) IF2018=5.700; IF5Y=6.016; Q1; 100 pkt;
  27. Dąbrowska S, Andrzejewska A, Strzemecki D, Muraca M, Janowski M, Łukomska B*: Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats. Journal of Neuroinflammation 2019 Nov;16(1):216. doi: 10.1186/s12974-019-1602-5. (original) IF2018=5.700; IF5Y=6.016; Q1; 100 pkt;
  28. Dąbrowska-Bouta B, Sulkowski G, Strużyński W, Strużyńska L*: Prolonged exposure to silver nanoparticles results in oxidative stress in cerebral myelin. Neurotoxicity Research 2019 Apr;35(3):495-504. doi: 10.1007/s12640-018-9977-0. (original) IF2018=3.311; IF5Y=3.245; Q2; 70 pkt;
  29. Dąbrowski J*, Czajka A, Zielińska-Turek J, Jaroszyński J, Furtak-Niczyporuk M, Mela A, Poniatowski ŁA, Drop B, Dorobek M, Barcikowska-Kotowicz M, Ziemba A: Brain functional reserve in the context of neuroplasticity after stroke. Neural Plasticity 2019 Feb 27;2019:9708905. doi: 10.1155/2019/9708905. (review) IF2018=3.591; IF5Y=3.708; Q2; 70 pkt;
  30. De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Ž, Rydén L, Tokgözoğlu L, Wood D, De Bacquer D, EUROASPIRE V collaborators, Writing Committee, Scientific Steering/ Executive Committee, Coordinating centre, Diabetes centre, Data management centre, Statistical analysis centre, Central laboratory, Study centres, organisations, investigators and other research personnel ( Kosior DA): Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis 2019 Apr 24;285:135-146. doi: 10.1016/j.atherosclerosis.2019.03.014. (original) IF2018=4.255; IF5Y=4.239; Q1; 140 pkt;
  31. Dec R, Koliński M, Dzwolak W*: Beyond amino acid sequence: disulfide bonds and the origins of the extreme amyloidogenic properties of insulin's H-fragment. FEBS Journal 2019;286:3194-3205. doi: 10.1111/febs.14849. (original) IF2018=4.739; IF5Y=4.432; Q1; 100 pkt;
  32. Diamandakis D*, Zieminska E*, Siwiec M*, Tokarski K*, Salinska E*, Lenart J*, Hess G*, Lazarewicz JW*: Tetrabromobisphenol A-induced depolarization of rat cerebellar granule cells: ex vivo and in vitro studies. Chemosphere 2019 May;223:64-73. doi: 10.1016/j.chemosphere.2019.02.032. (original) IF2018=5.108; IF5Y=5.089; Q1; 100 pkt;
  33. Domaszewska-Szostek A*, Krzyżanowska M, Siemionow M: Cell-based therapies for chronic wounds tested in clinical studies: review. Annals of Plastic Surgery 2019 Dec;83(6):e96-e109. doi: 10.1097/SAP.0000000000001947. (review) IF2018=1.448; IF5Y=1.623; Q3; 70 pkt;   
  34. Dowjat K*, Adayev T, Wojda U, Brzozowska K, Barczak A, Gabryelewicz T, Hwang YW: Abnormalities of DYRK1A-cytoskeleton complexes in the blood cells as potential biomarkers of Alzheimer's disease. Journal of Alzheimers Disease 2019;72(4):1059-1075. doi: 10.3233/JAD-190475. (original) IF2018=3.517; IF5Y=3.908; Q2; 100 pkt;
  35. Drela K, Stanaszek L, Nowakowski A, Kuczynska Z, Łukomska B*: Experimental strategies of mesenchymal stem cells propagation - adverse events and potential risk of functional changes. Stem Cells International 2019 Mar 6;2019:7012692. doi: 10.1155/2019/7012692. (review) IF2018=3.902; IF5Y=4.055; Q2; 100 pkt;        
  36. Fedorczyk B*, Lipiński PFJ, Puszko AK, Tymecka D, Wilenska B, Dudka W, Perret GY, Wieczorek R, Misicka A*: Triazolopeptides inhibiting the interaction between neuropilin-1 and vascular endothelial growth factor-165. Molecules 2019 May 6;24(9):1756. doi: 10.3390/molecules24091756. (original) IF2018=3.060; IF5Y=3.380; Q2; 100 pkt;
  37. Fiedorowicz M, Choragiewicz T, Thaler S, Schuettauf F, Nowakowska D, Wojtunik K, Reibaldi M, Avitabile T, Kocki T, Turski WA, Kaminska A, Grieb P, Zrenner E, Rejdak R, Toro MD*: Tryptophan and kynurenine pathway metabolites in animal models of retinal and optic nerve damage: different dynamics of changes. Frontiers in Physiology 2019 Oct 1;10:1254. doi: 10.3389/fphys.2019.01254. (original) IF2018=3.201; IF5Y=3.921; Q2; 100 pkt;
  38. Furtak-Niczyporuk M, Jaroszyński J, Mela A, Staniszewska A*, Piotrowska J, Zimmermann A, Czajka-Bełz A, Dreher P, Dąbrowski J, Kapka-Skrzypczak L: Odpady cytostatyczne i cytotoksyczne – zasady postępowania w Polsce (Cytostatic and cytotoxic waste - rules of conduct in Poland). Medycyna Pracy 2019 Jun 14;70(3):377-391. doi: 10.13075/mp.5893.00827. (review) IF2018=0.778; IF5Y=0.673; Q4; 40 pkt;
  39. Ganjam GK*, Bolte K, Matschke LA, Neitemeier S, Dolga AM, Höllerhage M, Höglinger GU, Adamczyk A, Decher N, Oertel WH, Culmsee C: Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons. Cell Death and Disease 2019 Nov 14;10(11):865. doi: 10.1038/s41419-019-2091-2. (original) IF2018=5.959; IF5Y=6.211; Q1; 140 pkt;
  40. Gawlik R*, Kurowski M, Kowalski M, Ziętkowski Z, Pokrywka A, Krysztofiak H, Krzywański J, Bugajski A, Bartuzi Z: Asthma and exercise-induced respiratory disorders in athletes. The position paper of the Polish Society of Allergology and Polish Society of Sports Medicine. Postępy Dermatologii i Alergologii (Advances in Dermatology and Allergology) 2019 Feb;36(1):1-10. doi: 10.5114/ada.2019.82820.  (review) IF2018=1.757; IF5Y=1.786; Q3; 70 pkt;
  41. Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Collaborators (1421): Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. (original) IF2018=59.102; IF5Y=54.664; Q1; 200 pkt;
  42. Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S,Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Collaborators (1421): Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. (original) IF2018=59.102; IF5Y=54.664; Q1; 200 pkt;
  43. Gilbert MP, Bain SC, Franek E, Jodar-Gimeno E, Naucck MA, Pratley R, Roginski R, Kerr Saraiva JF, Rasmussen S, Buse JB: Effect of liraglutide on cardiovascular outcomes in elderly patients: A post-hoc analysis of a randomized controlled trial. Annals of Internal Medicine 2019 Mar 19;170(6):423-426. doi: 10.7326/M18-1569. (letter – observation: brief research report) IF2018=19.315; IF5Y=19.676; Q1; 200 pkt;
  44. Golubczyk D, Malysz-Cymborska I, Kalkowski L, Janowski M*, Coates JR, Wojtkiewicz J, Maksymowicz W, Walczak P: The role of glia in canine degenerative myelopathy: relevance to human amyotrophic lateral sclerosis. Molecular Neurobiology 2019 Aug;56(8):5740-5748. doi: 10.1007/s12035-019-1488-3. (original) IF2018=4.586; IF5Y=4.643; Q1; 100 pkt;
  45. Gomes de Assis G*, Gasanov EV: BDNF and cortisol integrative system – plasticity vs. degeneration: implications of the Val66Met polymorphism. Frontiers in Neuroendocrinology 2019;55:100784. IF2018=7.852; IF5Y=9.421; Q1; 140 pkt;
  46. Górnicka-Pawlak E, Janowski M, Habich A , Jablonska A, Sypecka J, Lukomska B: Intra-arterial administration of human umbilical cord blood derived cells inversed learning asymmetry resulting from focal brain injury in rat. Frontiers in Neurology 2019 Aug 13;10:786. doi: 10.3389/fneur.2019.00786. (original) IF2018=2.635; IF5Y=3.233; Q3; 100 pkt;
  47. Grygorowicz T, Strużyńska L*: Early P2X7R-dependent activation of microglia during the asymptomatic phase of autoimmune encephalomyelitis. Inflammopharmacology 2019 Feb;27(1):129-137. doi: 10.1007/s10787-018-0528-3. (original) IF2018=3.838; IF5Y=3.530; Q1; 70 pkt;
  48. Hamann L*, Ruiz-Moreno JS, Szwed M, Mossakowska M, Lundvall L, Schumann RR, Opitz B, Puzianowska-Kuznicka M: STING SNP R293Q is associated with a decreased risk of aging-related diseases. Gerontology 2019;65(2):145-154. doi: 10.1159/000492972. (original) IF2018=3.353; IF5Y=4.086; Q2; 100 pkt;
  49. Hernandez I, Luna G, Rauch JN, Reis SA, Giroux M, Karch CM, Boctor D, Sibih YE, Storm NJ, Diaz A, Kaushik S, Żekanowski C, Kang AA, Hinman CR, Cerovac V, Guzman E, Zhou H, Haggarty SJ, Goate AM, Fisher SK, Cuervo AM, Kosik KS*: A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy. Science Translational Medicine 2019 Mar 27;11(485): eaat3005. doi: 10.1126/scitranslmed.aat3005. (original) IF2018=17.200; IF5Y=18.643; Q1; 200 pkt;
  50. Issat T, Nowicka MA, Oleksik TP, Zagozda M, Koziol K, Jakimiuk AA, P Lewandowski P, Jakimiuk AJ*: Serum progesterone concentrations on the day of oocyte retrieval above 9.23 Ng/Ml may predict ovarian hyperstimulation syndrome risk in in vitro fertilized patients. Journal of Physiology and Pharmacology 2019 Oct;70(5):801-806. doi: 10.26402/jpp.2019.5.15. (original) IF2018=2.544; IF5Y=2.457; Q2; 70 pkt;
  51. Janik A, Niewiadomska M, Perlińska-Lenart U, Lenart J, Kołakowski D, Skorupińska-Tudek K, Swiezewska E, Kruszewska JS*, Palamarczyk G: Inhibition of dephosphorylation of dolichyl diphosphate alters the synthesis of dolichol and hinders protein N-glycosylation and morphological transitions in Candida albicans. International Journal of Molecular Sciences 2019 Oct 12;20(20):5067. doi: 10.3390/ijms20205067. (original) IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  52. Janowska J, Gargas J, Ziemka-Nalecz M, Zalewska T, Buzanska L, Sypecka J*: Directed glial differentiation and transdifferentiation for neural tissue regeneration. Experimental Neurology 2019 Sep;319:112813. doi: 10.1016/j.expneurol.2018.08.010. (review) IF2018=4.562; IF5Y=4.682; Q1; 140 pkt;
  53. Jarmula A, Łusakowska A, Fichna JP, Topolewska M, Macias A, Johnson K, Töpf A, Straub V, Rosiak E, Szczepaniak K, Dunin-Horkawicz S, Maruszak A, Kaminska AM, Redowicz MJ*: ANO5 mutations in the Polish limb girdle muscular dystrophy patients: effects on the protein structure. Scientific Reports 2019 Aug 8;9(1):11533. doi: 10.1038/s41598-019-47849-3. (original) IF2018=4.011; IF5Y=4.525; Q1; 140 pkt;
  54. Jaroszyński J, Mela A, Furtak-Niczyporuk M, Poniatowski ŁA, Dąbrowski J, Czajka-Bełz A, Zimmermann A, Dreher P, Drop B, Staniszewska A*: Off-label use of medicinal products n legal rules and practices. Acta Poloniae Pharmaceutica - Drug Research 2019;76(4):621-628. doi: 10.32383/appdr/105795. (review) IF2018=0.447; IF5Y=0.803; Q4; 40 pkt;
  55. Jaworska J, Zalewska Z, Sypecka J, Ziemka-Nalecz M*: Effect of HDAC inhibitor, sodium butyrate, on neurogenesis in a rat model of neonatal hypoxia-ischemia. Potential mechanism of action. Molecular Neurobiology 2019 Sep;56(9):6341-6370. doi: 10.1007/s12035-019-1518-1. (original) IF2018=4.586; IF5Y=4.643; Q1; 100 pkt;
  56. Jezela-Stanek A*, Murcia PV, Jurkiewicz D, Iwanicka-Pronicka K, Jędrzejowska M, Krajewska-Walasek M, Płoski R: Novel variant in HDAC8 gene resulting in the severe Cornelia de Lange phenotype. Clinical Dysmorphology 2019 Jul;28(3):126-130. doi: 10.1097/MCD.0000000000000277. (original - case report) IF2018=0.760; IF5Y=0.583; Q4; 40 pkt;
  57. Jędrzejowska M, Dębek E, Kowalczyk B, Halat P, Kostera-Pruszczyk A, Ciara E, Jezela-Stanek A, Rydzanicz M, Kasperowicz P, Gos M*: The remarkable phenotypic variability of the p.Arg269His wariant in the TRPV4 gene. Muscle and Nerve 2019 Jan;59(1):129-133. doi: 10.1002/mus.26346. (original - short report) IF2018=2.393; IF5Y=2.640; Q3; 100 pkt;
  58. Jęśko H*, Lenkiewicz AM, Wilkaniec A, Adamczyk A: The interplay between parkin and alpha synuclein; possible implications for the pathogenesis of Parkinson’s disease. Acta Neurobiologiae Experimentalis 2019;79:277-290. doi: 10.21307/ane 2019 026. (original) IF2018=1.529; IF5Y=1.660; Q4; 70 pkt;
  59. Jęśko H, Stępień A, Lukiw WJ, Strosznajder RP*: The cross-talk between sphingolipids and insulin-like growth factor signaling: significance for aging and neurodegeneration. Molecular Neurobiology 2019 May;56(5):3501-3521. doi: 10.1007/s12035-018-1286-3. (review). IF2018=4.586; IF5Y=4.643; Q1; 100 pkt;
  60. Jęśko H, Wencel PL, Lukiw WJ, Strosznajder RP*: Modulatory effcts of Fingolimod (FTY720) on the expression of sphingolipid metabolism-related genes in an animal model of Alzheimer disease. Molecular Neurobiology  2019 Jan;56(1):174-185. doi: 10.1007/s12035-018-1040-x. (original) IF2018=4.586; IF5Y=4.643; Q1; 100 pkt;
  61. Jonas MI^, Kuryłowicz A^*, Bartoszewicz Z, Lisik W, Jonas M, Koźniewski K, Puzianowska-Kuznicka M: Vitamin D receptor gene expression in adipose tissue of obese individuals is regulated by miRNA and correlates with the pro-inflammatory cytokine level. International Journal of Molecular Sciences 2019 Oct 24;20(21):5272. doi: 10.3390/ijms20215272. (original) IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  62. Kaczyński T*, Wroński J, Głuszko P, Kryczka T, Miskiewicz A, Górski B, Radkowski M, Strzemecki D, Grieb P, Górska R: Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor  levels in patients with periodontitis and rheumatoid arthritis. Central European Journal of Immunology 2019;44(2):269-276). doi: IF2018=1.455; IF5Y=1.219; Q4; 40 pkt;
  63. Kala P, Červenka L*, Škaroupková P, Táborský M, Kompanowska-Jezierska E, Sadowski J: Sex-linked differences in the mortality in Ren-2 transgenic hypertensive rats with aorto-caval fistula: effects of treatment with angiotensin converting enzyme alone and combined with inhibitor of soluble epoxide hydrolase. Physiological Research 2019;68:589-601. (original) IF2018=1.701; IF5Y=1.669; Q4; 40 pkt;
  64. Kapelios CJ, Lainscak M, Savarese G, Laroche C, Seferovic P, Ruschitzka F, Coats A, Anker SD, Crespo-Leiro MG, Filippatos G, Piepoli MF, Rosano G, Zanolla L, Aguiar C, Murin J, Leszek P, McDonagh T, Maggioni AP, Lund LH*; HF-LT Registry Investigators Group. Collaborators (599, Pawlak A): Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world. European Journal of Heart Failure 2019;21:1383-1397. doi: 10.1002/ejhf.1532. (original) IF2018=12.129; IF5Y=9.014; Q1; 200 pkt;
  65. Kasprzycka P, Archacka K, Kowalski K, Mierzejewski B, Zimowska M, Grabowska I, Piotrowski M, Rafałko M, Ryżko A, Irhashava A, Senderowski K, Gołąbek M, Stremińska W, Jańczyk-Ilach K, Koblowska M, Iwanicka-Nowicka R, Fogtman A, Janowski M, Walczak P, Ciemerych MA, Brzoska E*: The factors present in regenerating muscles impact bone marrow-derived mesenchymal stromal/stem cell fusion with myoblasts. Stem Cell Research & Therapy 2019 Nov 21;10(1):343. doi: 10.1186/s13287-019-1444-1. (original) IF2018=4.627; IF5Y=5.363; Q1; 100 pkt;
  66. Ke T, Sidoryk-Wegrzynowicz M, Pajarillo E, Rizor A, Soares FAA, Lee E, Aschner M*: Role of astrocytes in manganese neurotoxicity revisited. Neurochemical Research 2019;44:2449-2459. doi: 10.1007/s11064-019-02881-7. (review) IF2018=2.782; IF5Y=2.804; Q3; 70 pkt;
  67. Kieroń M, Żekanowski C, Falk A, Wężyk M*: Oxidative DNA damage signalling in neural stem cells in Alzheimer's disease. Oxidative Medicine and Cellular Longevity 2019 Nov 13;2019:2149812. doi: 10.1155/2019/2149812. (review). IF2018=4.868; IF5Y=5.392; Q2; 100 pkt;
  68. Konop M*, Kłodzińska E, Borowiec J, Laskowska AK, Czuwara J, Konieczka P, Cieślik B, Waraksa E, Rudnicka L: Application of micellar electrokinetic chromatography for detection of silver nanoparticles released from wound dressing. Electrophoresis 2019 Jun;40(11):1565-1572. doi: 10.1002/elps.201900020. (original) IF2018=2.754; IF5Y=2.408; Q2; 70 pkt;
  69. Kopeć G*, Kurzyna M, Mroczek E, Chrzanowski Ł, Mularek-Kubzdela T, Skoczylas I, Kuśmierczyk B, Pruszczyk P, Błaszczak P, Lewicka E, Karasek D, Mizia-Stec K, Tomaszewski M, Jacheć W, Ptaszyńska-Kopczyńska K, Peregud-Pogorzelska M, Doboszyńska A, Pawlak A, Gąsior Z, Zabłocka W, Ryczek R, Widejko-Pietkiewicz K, Waligóra M, Darocha S, Furdal M, Ciurzyński M, Kasprzak JD, Grabka M, Kwiatkowska J, Kamiński K, Hoffman P, Podolec P, Torbicki A: Database of pulmonary hypertension in the Polish population (BNP PL): design of the registry. Kardiologia Polska 2019 Oct 25;77(10):972-974. doi: 10.33963/KP.14988. (short communication) IF2018=1.674; IF5Y=1.231; Q3; 70 pkt;
  70. Kopera E*, Zdanowski K, Uranowska K, Kosson P, Sączyńska V, Florys K, Szewczyk B: High-titre neutralizing antibodies to H1N1 influenza virus after mouse immunization with yeast expressed H1 antigen: a promising influenza vaccine candidate. Journal of Immunology Research 2019 Jan 8;2019:2463731. doi: 10.1155/2019/2463731. (original) IF2018=3.404; IF5Y=3.738; Q2; 100 pkt;
  71. Kotela A, Wojdasiewicz P, Łęgosz P*, Sarzyńska S, Drela K, Pulik Ł, Kaleta B, Kniotek M, Borysowski J, Poniatowski LA, Kotela I: Increased serum levels of progranulin (PGRN) in patients with haemophilic arthropathy. Clinical and Experimental Pharmacology and Physiology 2019;46(4):373-379. doi: 10.1111/1440-1681.13054. (original) IF2018=2.336; IF5Y=2.301; Q3; 100 pkt;
  72. Krátký V*, Kikerlová S, Husková Z, Sadowski J, Kolář F, Červenka L: Enhanced renal vascular responsiveness to angiotensin II and norepinephrine: a unique feature of female rats with congestive heart failure. Kidney & Blood Pressure Research 2019;44(5):1128-1141. doi: 10.1159/000502379. (original) IF2018=2.123; IF5Y=1.996; Q2; 70 pkt;
  73. Krug P, Kwiatkowska M, Mojzych I, Głowala P, Dorant S, Kępińska D, Chotkowski M, Janiszewska K, Stolarski J, Wiktorska K, Kaczyńska K, Mazur M*: Polypyrrole microcapsules loaded with gold nanoparticles: Perspectives for biomedical imaging. Synthetic Metals 2019;248:27-34. (original) IF2018=2.870; IF5Y=2.511; Q2; 70 pkt;
  74. Krug P, Mielczarek L, Wiktorska K, Kaczyńska K, Wojciechowski P, Andrzejewski K, Ofiara K, Szterk A, Mazur M*: Sulforaphane-conjugated selenium nanoparticles: Towards synergistic anticancer effect. Nanotechnology 2019;30(6):065101. (original) IF2018=3.399; IF5Y=3.403; Q1; 100 pkt;
  75. Krysztofiak H*, Młyńczak M, Folga A, Braksator W, Małek ŁA: Normal values for left ventricular mass in relation to lean body mass in child and adolescent athletes. Pediatric Cardiology 2019 Jan;40(1):204-208. doi: 10.1007/s00246-018-1982-9. (original) IF2018=1.413; IF5Y=1.545; Q3; 70 pkt;
  76. Krysztofiak H*, Młyńczak M, Małek ŁA, Folga A, Braksator W: Left ventricular mass is underestimated in overweight children because of incorrect body size variable chosen for normalization. PLoS One 2019 May 29;14(5):e0217637. doi: 10.1371/journal.pone.0217637. (original) IF2018=2.776; IF5Y=3.337; Q2; 100 pkt;
  77. Krysztofiak H*, Młyńczak M, Małek ŁA, Folga A, Braksator W: Left ventricular mass normalization for body size in children based on an allometrically adjusted ratio is as accurate as normalization based on the centile curves method. PLoS One 2019;14(11):e0225287. (original) IF2018=2.776; IF5Y=3.337; Q2; 100 pkt;
  78. Kuchniak K, Wyszogrodzka E, Chrapusta SJ, Czarna M, Michalak M, Płaźnik A, Krząścik P, Mierzejewski P, Taracha E*: Using anticipatory and drug-evoked appetitive ultrasonic vocalization for monitoring the rewarding effect of amphetamine in a rat model of drug self-administration. Behavioural Brain Research 2019 Aug 29;376:112187. doi: 10.1016/j.bbr.2019.112187. (original) IF2018=2.770; IF5Y=3.021; Q2; 100 pkt;
  79. Kuczeriszka M*, Walkowska A, Olszynski KH, Rafalowska J, Sadowski J, Kompanowska-Jezierska E: Arginine and tetrahydrobiopterin supplementation in rats with salt-induced blood pressure increase: minor hypotensive effect but improvement of renal haemodynamics. Journal of Physiology and Pharmacology 2019 Apr;70(2). doi: 10.26402/jpp.2019.2.05. (original) IF2018=2.544; IF5Y=2.457; Q2; 70 pkt;
  80. Lesniak WG, Chu C, Jablonska A, Du Y, Pomper MG, Walczak P, Janowski M*: A distinct advantage to intraarterial delivery of 89Zr-bevacizumab in PET imaging of mice with and without osmotic opening of the blood-brain barrier. Journal of Nuclear Medicine 2019 May;60(5):617-622. doi: 10.2967/jnumed.118.218792. (original) IF2018=7.354; IF5Y=6.738; Q1; 140 pkt;
  81. Leśniewski K, Kunert P*, Matyja E, Czernicki T, Wójtowicz K, Wojciechowski J, Marchel A: Trigone ventricular meningiomas – clinical characteristics, histopathology and results of surgical treatment. Neurologia i Neurochirurgia Polska 2019;53(1):34-42. doi: 10.5603/PJNNS.a2019.0007. (original) IF2018=1.006; IF5Y=0.980; Q4; 40 pkt;
  82. Lipiński PFJ*, Jarończyk M, Dobrowolski JC, Sadlej J*: Molecular dynamics of fentanyl bound to μ-opioid receptor. Journal of Molecular Modeling 2019 May 3;25(5):144. doi: 10.1007/s00894-019-3999-2. (original) IF2018=1.335; IF5Y=1.423; Q3 40 pkt;
  83. Lipiński PFJ*, Kosson P, Matalińska J, Roszkowski P, Czarnocki Z, Jarończyk M, Misicka A, Dobrowolski JC, Sadlej J*: Fentanyl family at the mu-opioid receptor: uniform assessment of binding and computational analysis. Molecules 2019 Feb 19;24(4):740. doi: 10.3390/molecules24040740. (original) IF2018=3.060; IF5Y=3.380; Q2; 100 pkt;
  84. Lipiński PFJ*, Szucs E, Jarończyk M, Kosson P, Banyhe S, Misicka A, Dobrowolski JC, Sadlej J: Affinity of fentanyl and its derivatives for the 1-receptor. MedChemComm 2019 Jun 13;10(7):1187-1191. doi: 10.1039/c9md00222g. (original) IF2018=2.394; IF5Y=2.266; Q3; 70 pkt;
  85. Łastowska M*, Trubicka J, Karkucińska-Więckowska A, Kaleta M, Tarasińska M, Perek-Polnik M, Sobocińska AA, Dembowska-Bagińska B, Grajkowska W, Matyja E: Immunohistochemical detection of ALK protein identifiesAPC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors. Brain Tumor Pathology 2019 Jan;36(1):1-6. doi: 10.1007/s10014-018-0331-2. (original) IF2018=3.509; IF5Y=2.284; Q1; 70 pkt;
  86. Łukomska B, Stanaszek L, Zuba-Surma EK, Legosz P, Sarzynska S, Drela K*: Challenges and controversies in human mesenchymal stem cells therapy. Stem Cells International 2019 Apr 9;2019:9628536. doi: 10.1155/2019/9628536. (review) IF2018=3.902; IF5Y=4.055; Q2; 100 pkt;
  87. Magini P, Smits DJ, Vandervore L, Schot R, Columbaro M, Kasteleijn E, van der Ent M, Palombo F, Lequin MH, Dremmen M, de Wit MCY, Severino M, Divizia MT, Striano P, Ordonez-Herrera N, Alhashem A, Al Fares A, Al Ghamdi M, Rolfs A, Bauer P, Demmers J, Verheijen FW, Wilke M, van Slegtenhorst M, van der Spek PJ, Seri M, Jansen AC, Stottmann RW, Hufnagel RB, Hopkin RJ, Aljeaid D, Wiszniewski W, Gawlinski P, Laure-Kamionowska M, Alkuraya FS, Akleh H, Stanley V, Musaev D, Gleeson JG, Zaki MS, Brunetti-Pierri N, Cappuccio G, Davidov B, Basel-Salmon L, Bazak L, Shahar NR, Bertoli-Avella A, Mirzaa GM, Dobyns WB, Pippucci T, Fornerod M, Mancini GMS*: Loss of SMPD4 causes a developmental disorder characterized by microcephaly and congenital arthrogryposis. American Journal of Human Genetics 2019 Oct 3;105(4):689-705. doi: 10.1016/j.ajhg.2019.08.006. (original) IF2018=9.924; IF5Y=9.968; Q1; 200 pkt;
  88. Majchrzak M, Drela K, Andrzejewska A, Figurska S, Rogujski P, Fiedorowicz M, Walczak P, Janowski M, Łukomska B, Stanaszek L*: SOD1/Rag2 mice with low copy number of SOD1 gene as a new long-living immunodeficient model of ALS. Scientific Reports 2019 Jan 28;9(1):799. doi: 10.1038/s41598-018-37235-w. (original) IF2018=4.011; IF5Y=4.525; Q1; 140 pkt;
  89. Majewska E, Márquez J, Albrecht J, Szeliga M*: Transfection with GLS2 glutaminase (GAB) sensitizes human glioblastoma cell lines to oxidative stress by a common mechanism involving suppression of the PI3K/AKT pathway. Cancers (Basel) 2019 Jan 19;11(1):115. doi: 10.3390/cancers11010115. (original) IF2018=6.162; IF5Y=N/A; Q1; 140 pkt;
  90. McClung MR,  O'Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, Reid IR, Kiel DP,  Cavallari I, Bonaca MP, Wiviott SD, de Villiers T, Ling X, Lippuner K, Nakamura T, Reginster J-Y, Rodriguez-Portales JA, Roux Ch, Zanchetta J, Zerbini CAF, Park J-G, Im K, Cange A, Grip LT,  Heyden N, DaSilva C, Cohn D, Massaad R, Scott BB, Verbruggen N, Gurner D, Miller DL, Blair ML, Polis AB, Stoch SA, Santora A, Lombardi A, Leung AT, Kaufman KD*, Sabatine MS, for the LOFT Investigators ( Franek E): Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. Lancet Diabetes and Endocrinology 2019 Dec;7(12):899-911. doi: 10.1016/S2213-8587(19)30346-8. (original) IF2018=59.102; IF5Y=54.664; Q1; 200 pkt;  
  91. Michorowska S*, Giebułtowicz J, Wolinowska R, Konopka A, Wilkaniec A, Krajewski P, Bulska E, Wroczyński P: Detection of ALDH3B2 in human placenta. International Journal of Molecular Sciences 2019 Dec 13;20(24):6292. doi: 10.3390/ijms20246292. (original) IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  92. Mietelska-Porowska A, Gąsiorowska A, Palasz E, Koss DJ, Riedel G, Niewiadomska G*: Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride. Journal of Neuroscience Methods 2019 May 1;319:47-59. doi: 10.1016/j.jneumeth.2018.11.009. (original) IF2018=2.785; IF5Y=2.907; Q2; 100 pkt;
  93. Milewski K*Bogacińska-Karaś M, Hilgier W, Albrecht J, Zielińska M: TNFα increases STAT3-mediated expression of glutaminase isoform KGA in cultured rat astrocytes. Cytokine 2019;123:154774. doi: 10.1016/j.cyto.2019.154774. (original) IF2018=3.078; IF5Y=3.315; Q2; 100 pkt;
  94. Miziak B, Walczak A, Szponar J,  Pluta R, Czuczwar SJ*: Drug-drug interactions between antiepileptics and cannabinoids. Expert Opinion on Drug Metabolism & Toxicology 2019;15:407-415. doi: 10.1080/17425255.2019.1605355. (review) IF2018=3.487; IF5Y=3.094; Q2; 100 pkt;
  95. Młyńczak M*, Kołodziejczyk A, Krysztofiak H, Ambroszkiewicz G, Żyliński M, Cybulski G: Cardiorespiratory profiling during simulated lunar mission using impedance pneumography. Biomedical Signal Processing and Control 2019;51:216-221. (original) IF2018=2.943; IF5Y=3.321; Q2; 140 pkt;
  96. Młyńczak M*, Krysztofiak H: Cardiorespiratory temporal causal links and the differences by sport or lack thereof. Frontiers in Physiology 2019 Feb 5;10:45. doi: 10.3389/fphys.2019.00045. (original) IF2018=3.201; IF5Y=3.921; Q2; 100 pkt;
  97. Możeńska M*, Bil J, Segiet A, Kosior DA: The influence of calcium-phosphate metabolism abnormalities on the quality of life in patients with hemodynamically significant mitral regurgitation. BMC Cardiovascular Disorders 2019;19:116. IF2018=1.947; IF5Y=2.124; Q3; 70 pkt;
  98. Olczak E, Kuryłowicz A, Wicik Z, Kolodziej P, Cakala-Jakimowicz M, Buyanovskaya O, Slusarczyk P, Mossakowska M, Puzianowska-Kuźnicka M*: Glucocorticoid receptor (NR3C1) gene polymorphisms are associated with age and blood parameters in Polish Caucasian nonagenarians and centenarians. Experimental Gerontology 2019 Feb;116:20-24. doi: 10.1016/j.exger.2018.12.006. (original) IF2018=3.080; IF5Y=3.597; Q2; 100 pkt;
  99. Olszewski WL*, Zaleska MT, Hydrabadi R, Banker M, Kurulkar P:  Edema fluid can be successfully evacuated from the lymphedematous limbs by implantation of silicone tubings bypassing the site of flow obstruction long-term observations. Lymphatic Research and Biology 2019;17(5):557-564. doi: 10.1089/lrb.2018.0042. (original) IF2018=1.493; IF5Y=1.942; Q4; 70 pkt;
  100. Onyszkiewicz M, Gawrys-Kopczynska M, Konopelski P, Aleksandrowicz M, Sawicka A, Koźniewska E, Samborowska E, Ufnal M*: Butyric acid, a gut bacteria metabolite, lowers arterial blood pressure via colon-vagus nerve signaling and GPR41/43 receptors. Pflügers Archiv - European Journal of Physiology 2019 Dec;471(11-12):1441-1453. (original) IF2018=3.377; IF5Y=3.286; Q2; 100 pkt;
  101. Ostrowski RP, Zhang JH*: The insights into molecular pathways of hypoxia-inducible factor in the brain. Journal of Neuroscience Research 2020:98(1):57-76. doi: 10.1002/jnr.24366. (review) IF2018=4.139; IF5Y=3.153; Q2; 70 pkt;
  102. Palasz E, Niewiadomski W, Gąsiorowska A, Mietelska-Porowska A, Niewiadomska G*: Neuroplasticity and neuroprotective effect of treadmill training in the chronic mouse model of Parkinson's disease. Neural Plasticity 2019 Apr 3;2019:8215017. doi: 10.1155/2019/8215017. (original) IF2018=3.591; IF5Y=3.708; Q2; 70 pkt;
  103. Palasz E,  Niewiadomski WGąsiorowska A,  Wysocka A,  Stepniewska A,  Niewiadomska G*: Exercise-induced neuroprotection and recovery of motor function in animal models of Parkinson's disease. Frontiers in Neurology  2019 Nov 1;10:1143. doi: 10.3389/fneur.2019.01143. (review) IF2018=2.635; IF5Y=3.233; Q3; 100 pkt;
  104. Pawlak A*, Rejmak-Kozicka E, Gil KE, Ziemba A, Kaczmarek L, Gil RJ: Patterns of desmin expression in idiopathic dilated cardiomyopathy are related to the desmin mRNA and ubiquitin expression. Journal of Investigative Medicine 2019 Jan;67(1):11-19. doi: 10.1136/jim-2017-000707. (original) IF2018=1.994; IF5Y=2.023; Q2; 70 pkt;
  105. Pepłońska B*, Safranow K, Adamczyk J, Boguszewski D, Szymański K, Soltyszewski I, Barczak A, Siewierski M, Ploski R, Sozanski H, Żekanowski C: Association of serotoninergic pathway gene variants with elite athletic status in the Polish population. Journal of Sports Sciences 2019 Jul;37(14):1655-1662. doi: 10.1080/02640414.2019.1583156. (original) IF2018=2.811; IF5Y=3.264; Q1; 100 pkt;
  106. Pilch Z, Tonecka K, Skorzynski M, Sas Z, Braniewska A, Kryczka T, Boon L, Golab J, Meyaard L, Rygiel TP*: The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies. PLoS One 2019 Jan 17;14(1):e0210796. doi: 10.1371/journal.pone.0210796. (original) IF2018=2.776; IF5Y=3.337; Q2; 100 pkt;
  107. Pluskiewicz W*, Adamczyk P, Franek E, Sewerynek E, Wichrowska H, Napiórkowska L, Stuss M, Rozwandowicz A, Drozdzowska B: The efficacy of pharmacotherapy in postmenopausal osteoporosis: a longitudinal observational study. Endokrynologia Polska 2019;70(6):473-477. doi: 10.5603/EP.a2019.0058. (original) IF2018=1.521; IF5Y=1.477; Q4; 40 pkt;
  108. Pluta R*^, Ułamek-Kozioł M^: The role of degenerative pathways in the development of irreversible consequences after brain ischemia. Neural Regeneration Research 2019;14:982-983. doi: 10.4103/1673-5374.250574 (perspective) IF2018=2.472; IF5Y=2.057; Q3; 70 pkt;
  109. Pluta R*, Ułamek-Kozioł M, Januszewski S, Czuczwar S: Amyloid pathology in the brain after ischemia. Folia Neuropathologica 2019;57(3):220-226. doi: 10.5114/fn.2019.88450. (review) IF2018=1.160; IF5Y=1.281; Q4; 40 pkt;
  110. Płońska-Gościniak E, Olędzki S*, Kukulski T, Kosmala W, Młynarski R, Oko-Sarnowska Z, Wojtkowska A, Gościniak P, Gąsior Z, Hryniewiecki T, Boczar K, Daniłowicz-Szymanowicz L, Kempa M, Jaroch J, Nowalany-Kozielska E, Lisowska A, Mizia-Stec K, Sinkiewicz W, Świątkiewicz I, Szyszka A, Kosior DA, Kasprzak JD: Pol-CDRIE registry - 1-year observational data on patients hospitalized due to cardiac device-related infective endocarditis in Polish referential cardiology centres. Kardiologia Polska 2019;77:561-567. doi: 10.33963/KP.14811. (original) IF2018=1.674; IF5Y=1.231; Q3; 70 pkt;
  111. Podlecka-Piętowska A, Kacka A*, Zakrzewska-Pniewska B, Nojszewska M, Zieminska E, Chalimoniuk M, Toczylowska B: Altered cerebrospinal fluid concentrations of hydrophobic and hydrophilic compounds in early stages of multiple sclerosis-metabolic profile analyses. Journal of Molecular Neuroscience 2019 Sep;69(1):94-105. doi: 10.1007/s12031-019-01336-6. (original) IF2018=2.577; IF5Y=2.294; Q3; 70 pkt;
  112. Pokorný M, Mrázová I, Kubátová H, Piťha J, Malý J, Pirk J, Maxová H, Melenovský V, Šochman J, Sadowski J, Červenka L*, Čermák Z, Volenec K, Netuka I: Intraventricular placement of a spring expander does not attenuate cardiac atrophy of the healthy heart induced by unloading via heterotopic heart transplantation. Physiological Research 2019;68:567-580. (original) IF2018=1.701; IF5Y=1.669; Q4; 40 pkt;
  113. Pratley RE*, Emerson SS, Franek E, Gilbert MP, Marso SP, McGuire DK, Pieber TR, Zinman B, Hansen CT, Hansen MV, Mark T, Moses AC, Buse JB; DEVOTE Study Group: Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: results from DEVOTE (DEVOTE 7). Diabetes, Obesity and Metabolism 2019 Jul;21(7):1625-1633. doi: 10.1111/dom.13699. (original) IF2018=6.133; IF5Y=6.055; Q1; 140 pkt;
  114. Pucko E*, Ostrowski R, Matyja E: Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro. Folia Neuropathologica 2019;57(3):239-248. doi: 10.5114/fn.2019.88452. (original) IF2018=1.160; IF5Y=1.281; Q4; 40 pkt;
  115. Puszko AK, Sosnowski P, Pułka-Ziach K, Hermine O, Hopfgartner G, Lepelletier Y, Misicka A*: Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A165/NRP-1 complex. Bioorganic and Medicinal Chemistry Letters 2019 Sep 1;29(17):2493-2497. doi: 10.1016/j.bmcl.2019.07.016. (review) IF2018=2.448; IF5Y=2.352; Q2; 70 pkt;
  116. Puszko AK*, Sosnowski P, Tymecka D, Raynaud F, Hermine O, Lepelletier Y, Misicka A*: Neuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method. MedChemComm 2019 Jan 25;10(2):332-340. doi: 10.1039/c8md00537k. (original) IF2018=2.394; IF5Y=2.266; Q3; 70 pkt;
  117. Puzianowska-Kuznicka M*, Kuryłowicz A, Walkiewicz D, Borkowska J, Owczarz M, Olszanecka-Glinianowicz M, Wieczorowska-Tobis K, Skalska A, Szybalska A, Mossakowska M: Obesity paradox in Caucasian seniors: results of the PolSenior study. Journal of Nutrition, Health and Aging 2019;23(9):796-804. doi:10.1007/s12603-019-1257-z. (original) IF2018=2.660; IF5Y=3.215; Q2; 100 pkt;
  118. Rachubik P*, Piwkowska A: The role of vasodilator-stimulated phosphoprotein in podocyte functioning. Cell Biology International 2019;43:1092-1101. doi: 10.1002/cbin.11149. (review) IF2018=2.127; IF5Y=1.899; Q4; 70 pkt;
  119. Robakiewicz I, Polak M, Rawska M, Alberski D, Polowy R, Wytrychiewicz K, Syperek M, Matysiak J, Filipkowski RK*: Stimulus-seeking in rats is accompanied by increased c Fos expression in hippocampal CA1 as well as short 22 kHz and flat 50 kHz calls. Acta Neurobiologiae Experimentalis 2019;79:310-318. doi: 10.21307/ane-2019-029. (original). IF2018=1.529; IF5Y=1.660; Q4; 70 pkt;
  120. Rusek M, Pluta R*, Ułamek-Kozioł M, Czuczwar SJ: Ketogenic diet in Alzheimer's disease. International Journal of Molecular Sciences 2019 Aug 9;20(16):3892. doi:10.3390/ijms20163892. (review) IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  121. Russjan E, Andrzejewski K, Sulejczak D, Kleczkowska P, Kaczyńska K*: Endomorphin-2 and neurotensin based chimeric peptide attenuates airway inflammation in mouse model of non-allergic asthma. International Journal of Molecular Sciences 2019;20(23):5935; doi: 10.3390/ijms20235935. (original) IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  122. Russjan E, Kaczyńska K*: Beneficial effects of neurotensin in murine model of hapten-induced asthma. International Journal of Molecular Sciences 2019 Oct 11;20(20):5025. doi: 10.3390/ijms20205025. (original) IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  123. Rydzanicz M, Wachowska M, Cook EC, Lisowski P, Kuźniewska B, Szymańska K, Diecke S, Prigione A, Szczałuba K, Szybińska A, Koppolu A, Murcia Pienkowski V, Kosińska J, Wiweger M, Kostrzewa G, Brzozowska M, Domańska-Pakieła D, Jurkiewicz E, Stawiński P, Gromadka A, Zielenkiewicz P, Demkow U, Dziembowska M, Kuźnicki J, Creamer TP, Płoski R*: Novel calcineurin A (PPP3CA) variant associated with epilepsy, constitutive enzyme activation and downregulation of protein expression. European Journal of Human Genetics 2019 Jan;27(1):61-69. doi: 10.1038/s41431-018-0254-8. (original) IF2018=3.650; IF5Y=3.907; Q2; 100 pkt;
  124. Serwach K, Gruszczynska-Biegala J*: STIM proteins and glutamate receptors in neurons: role in neuronal physiology and neurodegenerative diseases. International Journal of Molecular Sciences 2019 May 9;20(9):2289. doi: 10.3390/ijms20092289. (review) IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  125. Sidoryk-Węgrzynowicz M, Strużyńska L*: Astroglial contribution to tau-dependent neuro-degeneration. Biochemical Journal 2019;476(22):3493-3504. (review) IF2018=4.331; IF5Y=3.917; Q1; 100 pkt;
  126. Skowrońska K^, Obara-Michlewska M^, Czarnecka A, Dąbrowska K, Zielińska M, Albrecht J*: Persistent overexposure to N-methyl-D-aspartate (NMDA) calcium-dependently downregulates glutamine synthetase, aquaporin 4, and Kir4.1 channel in mouse cortical astrocytes. Neurotoxicity Research 2019 Jan;35(1):271-280. doi: 10.1007/s12640-018-9958-3. (original) IF2018=3.311; IF5Y=3.245; Q2; 70 pkt;
  127. Skowrońska K*, Obara-Michlewska M, Zielińska M, Albrecht J*: NMDA receptors in astrocytes: in search for roles in neurotransmission and astrocytic homeostasis. International Journal of Molecular Sciences 2019 Jan 14;20(2):309. doi: 10.3390/ijms20020309. (review) IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  128. Slama A, Śliwczyński A, Woźnica J, Zdrolik M, Wiśnicki B, Kubajek J, Turżańska-Wieczorek O, Gozdowski D, Wierzba W, Franek E*: Impact of air pollution on hospital admissions with a focus on respiratory diseases: a time-series multi-city analysis. Environmental Science and Pollution Research International 2019 Jun;26(17):16998-17009. doi: 10.1007/s11356-019-04781-3. (original) IF2018=2.916; IF5Y=3.208; Q2; 70 pkt;
  129. Sobczuk P, Teterycz P, Lugowska I, Klimczak A, Bylina E, Czarnecka AM, Kosela-Paterczyk H, Osuch C, Streb J, Rutkowski P*: Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure. Oncology Letters 2019 Sep;18(3):3373-3380. doi: 10.3892/ol.2019.10622. (original) IF2018=1.871; IF5Y=1.741; Q4 70 pkt  
  130. Sowinska M, Morawiak M, Bochyńska-Czyż M, Lipkowski AW, Ziemińska E, Zabłocka B, Urbanczyk-Lipkowska Z*: Molecular antioxidant properties and in vitro cell toxicity of the p-aminobenzoic acid (PABA) functionalized peptide dendrimers. Biomolecules 2019 Mar 5;9(3):89. doi: 10.3390/biom9030089. (original) IF2018=4.694; IF5Y=N/A; Q1; 100 pkt;
  131. Srivastava R, Jablonska A, Chu C, Gregg L, Bulte J, Koehler RC, Walczak P, Janowski M*: Biodistribution of glial progenitors in a 3D printed model of the piglet cerebral ventricular system. Stem Cells and Development 2019 Apr 15;28(8):515-527. doi: 10.1089/scd.2018.0172. (original) IF2018=3.147; IF5Y=3.590; Q2; 100 pkt;
  132. Stępień A*, Jędrzejowska M, Guzek K, Rekowski W, Stępowska J:  Reliability of four tests to assess body posture and the range of selected movements in individuals with spinal muscular atrophy. BMC Musculoskeletal Disorders 2019 Feb 7;20(1):54. doi: 10.1186/s12891-018-2389-8. (original) IF2018=2.002; IF5Y=2.381; Q2; 100 pkt;
  133. Stępniewska A, Budnik M*, Krzemiński K, Niewiadomski W, Gąsiorowska A, Opolski G, Kochanowski J, Mieczkowska K, Żukowska K, Szepietowska K, Kowalik R: Impaired hemodynamic response to tilt, handgrip and Valsalva manoeuvre in patients with takotsubo syndrome. Autonomic Neuroscience: Basic and Clinical 2019 Sep;220:102555. doi: 10.1016/j.autneu.2019.102555. (original) IF2018=2.247; IF5Y=2.110; Q3; 70 pkt;
  134. Sutkowska E*,  Sutkowski K,  Sokołowski M, Franek E, Dragan S: Distribution of the highest plantar pressure regions in patients with diabetes and its association with peripheral neuropathy, gender, age, and BMI: one centre study. Journal of Diabetes Research 2019 Jul 9;2019:7395769. doi:10.1155/2019/7395769 (original) IF2018=3.040; IF5Y=3.233; Q270 pkt  
  135. Synoradzki K, Grieb P*: Citicoline: a superior form of choline? Nutrients 2019 Jul 12;11(7):1569. doi: 10.3390/nu11071569. (discussion) IF2018=4.171; IF5Y=4.813; Q1; 140 pkt;
  136. Szereda-Przestaszewska M, Kaczyńska K*: Pharmacologically evoked apnoeas. Receptors and nervous pathways involved. Life Sciences 2019;217:237-242. j.lfs.2018.12.021. (review) IF2018=3.448; IF5Y=3.200; Q2; 70 pkt;
  137. Szrejder M*, Piwkowska A: AMPK signalling: Implications for podocyte biology in diabetic nephropathy. Biology of the Cell 2019 May;111(5):109-120. doi:10.1111/boc.201800077. (review) IF2018=3.863; IF5Y=3.259; Q2; 70 pkt;
  138. Teisseyre P*, Zufferey D, Słomka M: Cost-sensitive classifier chains: selecting low-cost features in multi-label classification. Pattern Recognition 2019;86:290-319. (original) IF2018=5.898; IF5Y=5.765; Q1; 140 pkt;
  139. Toro MD*, Nowomiejska K, Avitabile T, Rejdak R, Tripodi S, Porta A, Reibaldi M, Figus M, Posarelli C, Fiedorowicz M: Effect of resveratrol on in vitro and in  vivo models of diabetic retinophathy: a systematic review. International Journal of Molecular Sciences 2019 Jul 17;20(14):3503. doi: 10.3390/ijms20143503. (review) IF2018=4.183; IF5Y=4.331; Q2; 140 pkt;
  140. Tuchalska-Czuroń J*, Lenart J, Augustyniak J, Durlik M: Is mitochondrial DNA copy number a good prognostic marker in resectable pancreatic cancer? Pancreatology 2019 Jan;19(1):73-79. doi: 10.1016/j.pan.2018.11.009. (original) IF2018=3.241; IF5Y=3.208; Q2; 70 pkt;
  141. Ułamek-Kozioł M, Czuczwar SJ, Januszewski S, Pluta R*: Ketogenic diet and epilepsy. Nutrients 2019 Oct 18;11(10):2510. doi: 10.3390/nu11102510. (review) IF2018=4.171; IF5Y=4.813; Q1; 140 pkt;
  142. Ułamek-Kozioł M,  Czuczwar SJ,  Kocki J,  Januszewski S,  Bogucki J,  Bogucka-Kocka A,  Pluta R*: Dysregulation of autophagy, mitophagy, and apoptosis genes in the CA3 region of the hippocampus in the ischemic model of Alzheimer's disease in the rat. Journal of Alzheimers Disease 2019;72(4):1279-1286. doi: 10.3233/JAD-190966. (original) IF2018=3.517; IF5Y=3.908; Q2; 100 pkt;
  143. Uryga A*, Kasprowicz M, Burzyńska M, Calviello L, Kaczmarska K, Czosnyka M: Cerebral arterial time constant calculated from the middle and posterior arteries in healthy subjects. Journal of Clinical Monitoring and Computing 2019 Aug;33(4):605-613. doi: 10.1007/s10877-018-0207-3. (original) IF2018=2.179; IF5Y=1.935; Q3; 70 pkt;
  144. Uryga A*, Kasprowicz M, Calviello L, Diehl RR, Kaczmarska K, Czosnyka M:  Assessment of cerebral hemodynamic parameters using pulsatile versus non-pulsatile cerebral blood outflow  models. Journal of Clinical Monitoring and Computing 2019 Feb;33(1):85-94. doi: 10.1007/s10877-018-0136-1. (original) IF2018=2.179; IF5Y=1.935; Q3; 70 pkt;
  145. Vacková Š, Kikerlová S, Melenovsky V, Kolář F, Imig JD, Kompanowska-Jezierska E, Sadowski J, Červenka L*: Altered renal vascular responsiveness to vasoactive agents in rats with angiotensin II-dependent hypertension and congestive heart failure. Kidney and Blood Pressure Research 2019;44(4):792-809. doi: 10.1159/000501688. (original) IF2018=2.123; IF5Y=1.996; Q2; 70 pkt;
  146. Vacková Š, Kopkan L, Kikerlová S, Husková Z, Sadowski J, Kompanowska-Jezierska E, Hammock BD, Imig JD, Táborský M, Melenovský V, Červenka L*: Pharmacological blockade of soluble epoxide hydrolase attenuates the progression of congestive heart failure combined with chronic kidney disease: insights from studies with fawn-hooded hypertensive rats. Frontiers in Pharmacology 2019 Jan 23;10:18. doi: 10.3389/fphar.2019.00018. (original) IF2018=3.845; IF5Y=4.469; Q1; 100 pkt;
  147. Vaněčková I*, Hojná S, Kadlecová M, Kompanowska-Jezierska E, Zicha J: Distinct effects of bosentan on NO-dependent vasodilation and calcium influx in heterozygous Ren-2 transgenic rats on high-salt diet. Physiological Research 2019 Oct 25;68(5):717-725. (original) IF2018=1.701; IF5Y=1.669; Q4; 40 pkt;
  148. Vaněčková I*, Hojná S, Vernerová Z, Kadlecová M, Rauchová H, Kompanowska-Jezierska E, Vaňourková Z, Červenka L, Zicha J: Renoprotection provided by additional diuretic treatment in partially nephrectomized Ren-2 transgenic rats subjected to the combined RAS and ETA blockade. Frontiers in Physiology 2019 Sep 18;10:1145. doi: 10.3389/fphys.2019.01145. (original) IF2018=3.201; IF5Y=3.921; Q2; 100 pkt;
  149. Viggiano E, Madej-Pilarczyk A, Carboni N, Picillo E, Ergoli M, del Gaudio S, Marchel M, Nigro G, Palladino A, Politano L*: X-linked Emery-Dreifuss muscular dystrophy: study of X-chromosome inactivation and its relation with clinical phenotypes in female carriers. Genes 2019;10(11):919; doi: 10.3390/genes10110919. (original) IF2018=3.331; IF5Y=3.484; Q2; 100 pkt;
  150. Walicka M, Jozwiak J, Rzeszotarski J, Zonenberg A, Masierek M, Bijos P, Franek E*: Diagnostic accuracy of glycated haemoglobin and average glucose values in type 2 diabetes mellitus treated with premixed insulin. Diabetes Therapy 2019 Apr;10(2):587-596. doi: 10.1007/s13300-019-0570-1. (original) IF2018=2.827; IF5Y=2.872; Q3; 100 pkt;
  151. Walkowska A*, Vaneckova I, Sadowski J, Kompanowska-Jezierska E: Rapid blood pressure increase after renal denervation in anaesthetized rats: interaction of oxidative stress and neuronal nitric oxide synthase. Journal of Physiology and Pharmacology 2019;70(4):613-618. doi: 10.264002/ jpp.2019.4.12. (original) IF2018=2.544; IF5Y=2.457; Q2; 70 pkt;
  152. Wełniak-Kamińska M, Fiedorowicz M*, Orzel J, Bogorodzki P, Modlinska K, Stryjek R, Chrzanowska A, Pisula W, Grieb P: Volumes of brain structures in captive wild-type and laboratory rats: 7T magnetic resonance in vivo automatic atlas-based study. PLoS One 2019 Apr 11;14(4):e0215348. doi: 10.1371/journal.pone.0215348. (original) IF2018=2.776; IF5Y=3.337; Q2; 100 pkt;
  153. Wilenska B*, Tymecka D, Włodarczyk M, Sobolewska-Włodarczyk A, Wiśniewska-Jarosińska M, Dyniewicz J, Somogyi Á, Fichna J, Misicka A*: Enkephalin degradation in serum of patients with inflammatory bowel diseases. Pharmacological Reports 2019 Feb;71(1):42-47. doi: 10.1016/j.pharep.2018.08.001. (original) IF2018=2.761; IF5Y=2.840; Q2; 70 pkt;
  154. Wilkaniec A, Lenkiewicz AM, Czapski GA, Jęśko HM, Hilgier W, Brodzik R, Gąssowska-Dobrowolska M, Culmsee C, Adamczyk A*: Extracellular alpha-synuclein oligomers induce parkin S-nitrosylation: relevance to sporadic Parkinson's disease etiopathology. Molecular Neurobiology  2019 Jan;56(1):125-140. doi: 10.1007/s12035-018-1082-0. (original) IF2018=4.586; IF5Y=4.643; Q1; 100 pkt;
  155. Wyskida M*, Owczarek AJ, Chełmecka E, Szczerbowska I, Mossakowska M, Grodzicki T, Puzianowska-Kuźnicka M, Olszanecka-Glinianowicz M, Chudek J: Parathyroid hormone response to different vitamin D levels in population-based old and very-old Polish cohorts. Experimental Gerontology 2019 Nov;127:110735. doi: 10.1016/j.exger.2019.110735. (original) IF2018=3.080; IF5Y=3.597; Q2; 100 pkt;
  156. Zaleska MT, Olszewski WL*: The effectiveness of intermittent pneumatic compression in therapy of lymphedema of lower limbs: methods of evaluation and results. Lymphatic Research and Biology 2019 Feb;17(1):60-69. doi: 10.1089/lrb.2018.0005. (original) IF2018=1.493; IF5Y=1.942; Q4; 70 pkt;
  157. Zaleska MT, Olszewski WL*, Ross J: The long-term arterial assist intermittent pneumatic compression generating venous flow obstruction is responsible for improvement of arterial flow in ischemic legs. PLoS One 2019 Dec 11;14(12):e0225950. doi: 10.1371/journal.pone.0225950. (original) IF2018=2.776; IF5Y=3.337; Q2; 100 pkt;
  158. Zatorski H, Salaga M, Zielińska M, Wasilewski A, Misicka A, Sacharczuk M, Fichna J*: High activity of endogenous opioid system protects against gastric damage development in mouse models of gastric mucosal injury. Pharmacological Reports 2019 Apr;71(2):218-224. doi: 10.1016/j.pharep.2018.10.011. (original) IF2018=2.761; IF5Y=2.840; Q2; 70 pkt;
  159. Zembrzuska K, Ostrowski RP, Matyja E*: Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro. Oncology Reports 2019 May;41(5):2703-2716. doi: 10.3892/or.2019.7064. (original) IF2018=3.041; IF5Y=2.899; Q3; 70 pkt;
  160. Zychowicz M, Pietrucha K, Podobinska M, Kowalska-Wlodarczyk M, Lenart J, Augustyniak J, Buzanska L*: The collagen scaffold supports hiPSC-derived NSC growth and restricts hiPSC. Frontiers in Bioscience (Schol Ed) 2019 Mar 1;11:105-121. (original) IF2018=2.214; IF5Y=2.302; Q3; 70 pkt;